WO2002040055A3 - Solutions and films of glycated chitosan - Google Patents

Solutions and films of glycated chitosan Download PDF

Info

Publication number
WO2002040055A3
WO2002040055A3 PCT/US2001/043673 US0143673W WO0240055A3 WO 2002040055 A3 WO2002040055 A3 WO 2002040055A3 US 0143673 W US0143673 W US 0143673W WO 0240055 A3 WO0240055 A3 WO 0240055A3
Authority
WO
WIPO (PCT)
Prior art keywords
glycated
chitosan
glycated chitosan
films
solutions
Prior art date
Application number
PCT/US2001/043673
Other languages
French (fr)
Other versions
WO2002040055A2 (en
Inventor
Robert E Nordquist
Raoul Carubelli
Original Assignee
Wound Healing Of Oklahoma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wound Healing Of Oklahoma Inc filed Critical Wound Healing Of Oklahoma Inc
Priority to AU2002219823A priority Critical patent/AU2002219823A1/en
Publication of WO2002040055A2 publication Critical patent/WO2002040055A2/en
Publication of WO2002040055A3 publication Critical patent/WO2002040055A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Preparations containing glycated chitosan in a physiologically compatible carrier are described. Viscoelastic preparations comprise 1.0-12.0 percent by weight of glycated chitosan in an aqueous solution while tower viscosity solutions possess 0.1-0.5 percent by weight glycated chitosan. The otherwise free amino groups of the chitosan polymer are preferably 30-90% glycated and possess an average molecular weight of between 100,000 and 2,000,000 Daltons, and, most preferably between 100,000 and 1,000,000 Daltons.
PCT/US2001/043673 2000-11-17 2001-11-16 Solutions and films of glycated chitosan WO2002040055A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002219823A AU2002219823A1 (en) 2000-11-17 2001-11-16 Solutions and films of glycated chitosan

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/715,429 US6756363B1 (en) 2000-11-17 2000-11-17 Solutions and films of glycated chitosan
US09/715,429 2000-11-17

Publications (2)

Publication Number Publication Date
WO2002040055A2 WO2002040055A2 (en) 2002-05-23
WO2002040055A3 true WO2002040055A3 (en) 2003-12-31

Family

ID=24874014

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/043673 WO2002040055A2 (en) 2000-11-17 2001-11-16 Solutions and films of glycated chitosan

Country Status (3)

Country Link
US (3) US6756363B1 (en)
AU (1) AU2002219823A1 (en)
WO (1) WO2002040055A2 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2491866T3 (en) * 1999-11-15 2014-09-08 Piramal Healthcare (Canada) Limited Temperature-controlled, pH-dependent, self-gelling aqueous biopolymer solution
US20030158302A1 (en) * 1999-12-09 2003-08-21 Cyric Chaput Mineral-polymer hybrid composition
ATE243049T1 (en) * 1999-12-09 2003-07-15 Biosyntech Canada Inc MINERAL-POLYMER HYBRID COMPOSITION
DK1294414T3 (en) * 2000-06-29 2006-07-24 Biosyntech Canada Inc Preparation and method of healing and regenerating cartilage and other tissues
US20040091540A1 (en) * 2000-11-15 2004-05-13 Desrosiers Eric Andre Method for restoring a damaged or degenerated intervertebral disc
US6756363B1 (en) * 2000-11-17 2004-06-29 Wound Healing Of Oklahoma, Inc. Solutions and films of glycated chitosan
DE102004040243A1 (en) * 2003-08-22 2005-03-17 Heppe, Katja, Dipl.-Biotechnol. Transport system for overcoming the blood-brain barrier, useful for the treatment and diagnosis of brain-specific diseases, comprises chitin, chitosan, chitosan oligosaccharides or glucosamine
US20060210513A1 (en) * 2005-03-21 2006-09-21 Joseph Luizzi Method of using skin compositions including tensioning polymers
CA2518298A1 (en) * 2005-09-06 2007-03-06 Chaimed Technologies Inc. Biodegradable polymers, their preparation and their use for the manufacture of bandages
AR056499A1 (en) * 2005-09-06 2007-10-10 Serapis Farmaceuticals Ltd COMPOUNDS
WO2007059605A1 (en) * 2005-11-04 2007-05-31 Bio Syntech Canada Inc. Composition and method for efficient delivery of nucleic acids to cells using chitosan
US20080289088A1 (en) * 2005-11-07 2008-11-27 E.I. Du Pont De Nemours And Company N-alkylchitosan films and laminates made therefrom
ITRM20060204A1 (en) 2006-04-10 2007-10-11 Vincenzo Savica PHARMACEUTICALS AND PHARMACEUTICALS FOR HYPERPROTIC HYPROPROSTICAL NORMOPROTEIC DIETS ALL HYPOPHOSPHORIC AND HYPOFOSPHORIC DRINKS
ITPD20060202A1 (en) * 2006-05-22 2007-11-23 Univ Degli Studi Trieste POLYMERIC MIXTURES OF ANIONIC AND CATIONIC POLYSACCHARIDES AND THEIR USE
ITPD20060203A1 (en) * 2006-05-22 2007-11-23 Univ Degli Studi Trieste HYDROGELS OF POLYSACCHARID MIXTURES FOR TISSUE ENGINEERING AND THE VEHICLE OF ACTIVE COMPOUNDS
CA2676919C (en) * 2007-01-31 2013-01-29 Allergan, Inc. Novel biomaterials for ocular drug delivery and a method for making and using same
FR2919189A1 (en) * 2007-07-26 2009-01-30 Cyclopharma Sa Lab NOVEL COMPOSITIONS BASED ON POLYOSIDES GRAFTED BY POLYAMINE OR POLYSOUFRE COMPOUNDS.
FR2934162B1 (en) * 2008-07-23 2012-08-17 Millet Innovation DERMAL STAMP FOR THE APPLICATION OF DRY ACTIVE ASSETS
CN102597009B (en) * 2009-05-27 2016-06-22 切卢科技公司 The polymer prepared by Primary amine-functionalised polymer and hemicellulose
CN101875704A (en) * 2010-06-25 2010-11-03 浙江工业大学 Water-soluble chitosan schiff base derivative and preparation method and application thereof
US8664198B2 (en) 2011-02-28 2014-03-04 The University Of Central Oklahoma Immunologically modified carbon nanotubes for cancer treatment
KR20220028153A (en) * 2012-01-20 2022-03-08 임무노포토닉스 인코퍼레이티드 Chitosan-derived compositions
US11773188B2 (en) 2012-01-20 2023-10-03 Immunophotonics, Inc Chitosan-derived compositions
US20190002594A1 (en) 2014-07-16 2019-01-03 Immunophotonics, Inc. Chitosan-Derived Compositions
CN105237655B (en) * 2015-10-08 2017-04-12 中国科学院海洋研究所 Marine organism polysaccharide Schiff base derivative, preparation method thereof, and application thereof as agricultural bactericide
CN105131152B (en) * 2015-10-08 2017-04-05 中国科学院海洋研究所 A kind of marine polysaccharide copper composition and prepare and as the application of disinfectant use in agriculture
CN105903087A (en) * 2015-12-14 2016-08-31 上海其胜生物制剂有限公司 Preparation method of viscoelastic agent with cohesiveness and dispersivity
IT201700060530A1 (en) * 2017-06-01 2018-12-01 Jointherapeutics S R L HYDRO-SOLUBLE POLYESACCHARID DERIVATIVES, THEIR PREPARATION PROCEDURE AND THEIR USES
IT201700122135A1 (en) * 2017-10-26 2019-04-26 Jointherapeutics S R L HYALURONIC ACID FUNCTIONALIZED OR ITS DERIVATIVE IN THE TREATMENT OF INFLAMMATORY STATES
US20200010575A1 (en) * 2018-07-05 2020-01-09 Immunophotonics, Inc. Semi-synthetic biopolymers for use in treating proliferative disorders
AU2021260578A1 (en) 2020-04-20 2022-11-03 Board Of Regents, The University Of Texas System Biologically active dry powder compositions and method of their manufacture and use
WO2023049167A1 (en) * 2021-09-21 2023-03-30 Immunophotonics, Inc. Methods for producing glycated chitosans

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4424346A (en) * 1981-06-04 1984-01-03 Canadian Patents And Development Ltd. Derivatives of chitins, chitosans and other polysaccharides
JPH02134310A (en) * 1988-11-14 1990-05-23 Kao Corp Skin detergent
US5747475A (en) * 1995-04-04 1998-05-05 Wound Healing Of Oklahoma Chitosan-derived biomaterials
JPH1143441A (en) * 1997-07-29 1999-02-16 Ichimaru Pharcos Co Ltd Preventive and therapeutic agent for disease of fish and shellfish
DE19857546A1 (en) * 1998-12-14 2000-06-15 Cognis Deutschland Gmbh New N-substituted chitan and chitosan derivatives, useful as hydrocolloid in cosmetics and pharmaceuticals, with good solubility in basic and neutral media

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US4965253A (en) 1987-10-14 1990-10-23 University Of Florida Viscoelastic material for ophthalmic surgery
US5510329A (en) 1988-04-26 1996-04-23 Ramot University For Applied Research And Industrial Development Ltd. Preparations for the treatment of eyes
US5093319A (en) 1989-10-31 1992-03-03 Pfizer Hospital Products Group, Inc. Use of derivatives of chitin soluble in aqueous solutions for preventing adhesions
DE69432188T2 (en) 1993-04-30 2004-01-22 Nestle S.A. Synthetic viscose elastic material for physiological applications such as for ophthalmic applications
TW389694B (en) * 1995-08-17 2000-05-11 Novartis Ag Compositions including o-carboxyalkyl chitosan and methods of use in ophthalmics
US6277792B1 (en) 1998-12-28 2001-08-21 Venture Innovations, Inc. Viscosified aqueous fluids and viscosifier therefor
US6756363B1 (en) * 2000-11-17 2004-06-29 Wound Healing Of Oklahoma, Inc. Solutions and films of glycated chitosan

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4424346A (en) * 1981-06-04 1984-01-03 Canadian Patents And Development Ltd. Derivatives of chitins, chitosans and other polysaccharides
JPH02134310A (en) * 1988-11-14 1990-05-23 Kao Corp Skin detergent
US5747475A (en) * 1995-04-04 1998-05-05 Wound Healing Of Oklahoma Chitosan-derived biomaterials
JPH1143441A (en) * 1997-07-29 1999-02-16 Ichimaru Pharcos Co Ltd Preventive and therapeutic agent for disease of fish and shellfish
DE19857546A1 (en) * 1998-12-14 2000-06-15 Cognis Deutschland Gmbh New N-substituted chitan and chitosan derivatives, useful as hydrocolloid in cosmetics and pharmaceuticals, with good solubility in basic and neutral media

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 014, no. 370 (C - 0747) 10 August 1990 (1990-08-10) *
PATENT ABSTRACTS OF JAPAN vol. 1999, no. 05 31 May 1999 (1999-05-31) *
YALPANI M ET AL: "Some chemical and analytical aspects of polysaccharide modifications. 3. Formation of branched-chain, soluble chitosan derivatives", MACROMOLECULES, vol. 17, 1984, ISSN: 0024-9297, pages 272 - 281, XP002206891 *
YALPANI M ET AL: "Unusual rheology of a branched water-soluble chitosan derivative", NATURE (LONDON), vol. 302, no. 5911, 1983, pages 812 - 814, XP002206892, ISSN: 0028-0836 *

Also Published As

Publication number Publication date
US20060189573A1 (en) 2006-08-24
US6756363B1 (en) 2004-06-29
AU2002219823A1 (en) 2002-05-27
US20050130932A1 (en) 2005-06-16
WO2002040055A2 (en) 2002-05-23

Similar Documents

Publication Publication Date Title
WO2002040055A3 (en) Solutions and films of glycated chitosan
CA2331264A1 (en) Compositions and methods for drug delivery
WO2003000226A3 (en) Pharmaceutical compositions containing polymer and drug assemblies
WO2005058366A3 (en) Compositions comprising two different populations of polymer-active agent conjugates
EP1064909A3 (en) High internal aqueous phase water-in-oil type emulsion cosmetic composition
CA2323925A1 (en) Crosslinkable macromers bearing initiator groups
CA2228505A1 (en) Fluoroligomer surface modifiers for polymers and articles made therefrom
CA2311438A1 (en) Self-tanning mousse
CA2161004A1 (en) Active ingredient patch
WO2002100437A3 (en) Ophthalmic compositions comprising hyaluronic acid
AU7295900A (en) Aqueous gelled composition comprising a block copolymer including at least a water soluble block and a hydrophobic block
CA2379672A1 (en) Biodegradable poly(alkylene oxide)-poly(p-dioxanone) block copolymer soluble in organic solvents, and drug delivery composition comprising same
WO2004060406A3 (en) Polymeric reagents comprising a ketone or a related functional group
EP1880717A3 (en) Systems, Methods and apparatuses for manufacturing dosage forms
EP0683207A3 (en) L-lactic acid polymer composition, molded product and film.
WO2001044215A3 (en) Fungicidal combinations of active substances
WO2003011226A3 (en) Products and drug delivery vehicles
AU3764899A (en) High molecular weight polyols, process for preparation and use thereof
AU3238001A (en) Low molecular weight polymannuronate
CA2253833A1 (en) Derivatives of k5 polysaccharide having high anticoagulant activity
AU2003214133A1 (en) Topical composition comprising a cyclofructan, a carrier and a drug
AU5376500A (en) Functional poly-alpha-aminoacid derivatives useful for the modification of biologically active materials and their application
ES8700145A1 (en) A flavoured tablet having a high flavour intensity.
AU2001277605A1 (en) High molecular weight cationic polymers, preparation method and uses thereof
EP0882447B8 (en) Soluble cosmetics

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EC EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP